We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News   Aug 04, 2020 | Original story from the National Institutes of Health

 
NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19
 
 
Advertisement
 

RELATED ARTICLES

Could a Lipid Be Used To Prevent or Treat SARS-CoV-2 Infection?

News

Researchers have discovered a lipid found in the human body that could be used to prevent or treat infections with SARS-CoV-2.

READ MORE

Understanding How Cisplatin Chemotherapy Causes Neuronal Damage

News

Researchers have shown that Cisplatin induces senescence of peripheral neurons through overexpression of the p21 protein, which would explain the neuropathy associated with this treatment.

READ MORE

Novel Drug Disarms Cancer-Causing Protein Aurora

News

Aurora-A kinase is a protein that causes extensive damage to cells of the body and is known to trigger the development of leukemias and many pediatric cancers, such as neuroblastoma. Researchers at the universities of Würzburg and Frankfurt have now developed a drug that can disarm Aurora.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE